ARCHIVES

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 34 | September 14, 2012

Download PDF Visit The Full Archive

Related Articles

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013